Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;21(3):193-200.
doi: 10.1097/MOH.0000000000000039.

Malaria parasites and red cell variants: when a house is not a home

Affiliations
Review

Malaria parasites and red cell variants: when a house is not a home

Steve M Taylor et al. Curr Opin Hematol. 2014 May.

Abstract

Purpose of review: Multiple red cell variants are known to confer protection from malaria. Here, we review advances in identifying new variants that modulate malaria risk and in defining molecular mechanisms that mediate malaria protection.

Recent findings: New red cell variants, including an innate variant in the red cell's major Ca²⁺ pump and the acquired state of iron deficiency, have been associated with protection from clinical falciparum malaria. The polymorphisms hemoglobin C (HbC) and hemoglobin S (HbS) - known to protect carriers from severe falciparum malaria - enhance parasite passage to mosquitoes and may promote malaria transmission. At the molecular level, substantial advances have been made in understanding the impact of HbS and HbC upon the interactions between host microRNAs and Plasmodium falciparum protein translation; remodeling of red cell cytoskeletal components and transport of parasite proteins to the red cell surface; and chronic activation of the human innate immune system, which induces tolerance to blood-stage parasites. Several polymorphisms have now been associated with protection from clinical vivax malaria or reduced Plasmodium vivax density, including Southeast Asian ovalocytosis and two common forms of glucose-6-phosphate dehydrogenase deficiency.

Summary: Red cell variants that modulate malaria risk can serve as models to identify clinically relevant mechanisms of pathogenesis, and thus define parasite and host targets for next-generation therapies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

There are no conflicts of interest.

Figures

Figure 1
Figure 1. Diverse mechanisms by which red cell variants may influence malaria pathogenesis
A. Plasmodium spp. parasites invade, mature, and replicate in red cells, and these events may be disrupted by a variety of mechanisms including the influence of host microRNAs on parasite protein translation, as described by LaMonte et al. (34). B. P. falciparum-infected red cells cause disease by binding to extracellular receptors on the surface of microvascular endothelial cells, uninfected red cells, and placental syncytiotrophoblasts via the parasite-derived surface antigen PfEMP1; trafficking of PfEMP1 to the red cell surface is impaired in HbS- and HbC-containing cells owing to a disruption of the parasite’s remodeling of the cell’s actin cytoskeleton, as described by Cyrklaff et al. (33). C. Activation of the innate immune system by infected red cells, parasite DNA, and free heme can alter the balance of pro- and anti-inflammatory cytokines to influence pathogenesis, as described by Ferreira et al. (41). These investigators propose that the chronic release of free heme from HbS-containing red cells activates heme oxygenase-1, which then mediates tolerance of Plasmodium parasites in a murine model of cerebral malaria. D. Plasmodium spp. parasites may be cleared more efficiently by the adaptive immune system when infecting red cell variants, though Tan et al. (40) report that children with β-globin variants did not acquire antibodies to P. falciparum proteins more rapidly or efficiently than children with normal β-globins. Originally published in Taylor SM, Cerami C, Fairhurst RM. Hemoglobinopathies: Slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathogens 2013;9:e1003327. Made available under the Creative Commons Attribution CCBY license.
Figure 2
Figure 2. Tolerance of Plasmodium falciparum hyperparasitemia
A 2-year-old Malian boy presented with a history of fever and malaise. Thick and thin blood films stained with Giemsa showed 273,450 parasites per µL of whole blood (A) and 25.7% parasitemia (B), respectively. At this time, he had a normal temperature (36.9°C) and moderate anemia (Hb level 7.8 g/dL). The child received artesunate and amodiaquine over 3 days, never developed symptoms or signs of severe malaria, and was later found to carry the sickle-cell trait. This case was originally published in Blood. Beaudry JT, Fairhurst RM. Microvascular sequestration of Plasmodium falciparum. Blood. 2011;117:6410. © the American Society of Hematology.

References

    1. Haldane JB. The rate of mutation of human genes. Hereditas. 1949;35:267–273.
    1. Taylor SM, Parobek CM, Fairhurst RM. Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(6):457–468. - PMC - PubMed
    1. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007;4(3):e66. - PMC - PubMed
    1. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, et al. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Nat Acad Sci USA. 2007;104(44):17471–17476. - PMC - PubMed
    1. May J, Evans JA, Timmann C, Ehmen C, Busch W, Thye T, et al. Hemoglobin variants and disease manifestations in severe falciparum malaria. JAMA. 2007;297(20):2220–2226. - PubMed

Publication types